Medivir AB Profit Margin

The latest profit margin for MVIR.ST is -2011.46% as of December 2022. That compares with -247.18% in the prior-year period — down 713.8% year over year. That is below the Healthcare sector average of 9.48%. Investors often review this figure alongside Medivir AB's historical trend and sector peers before judging valuation or financial health.

Over the past year, MVIR.ST's profit margin moved from -247.18% to -2011.46% — a 713.8% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Medivir AB's valuation or profitability profile.

Against Healthcare companies, MVIR.ST currently prints -2011.46% for profit margin, while the sector average sits near 9.48%. That is roughly 21315.7% below the sector mean. Large gaps often invite a closer look at Medivir AB's growth, margins, and balance sheet.

Profit Margin shows how effectively Medivir AB converts resources into returns. At -2011.46%, MVIR.ST may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with -247.18% in the prior-year period — down 713.8% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.

After noting MVIR.ST's profit margin (-2011.46%), review year-over-year change from -247.18%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.